Advisory Board May 30, 2024

Although weight-loss drugs have grown significantly in popularity over the last few years, not all patients have seen beneficial results, and many patients stop taking the drugs before they can be effective. To help patients overcome potential deterrents to these drugs, health experts say that more counseling and support from providers is needed.

What the headlines get wrong about weight-management medications

Weight-loss drugs affect patients differently

In clinical trials, researchers found that GLP-1 drugs like Wegovy and Zepbound helped patients lose at least 10% of their starting weight. However, new research suggests that the real-world efficacy of these drugs is lower than the clinical trial data suggests.

In a new report from Dandelion Health, researchers analyzed EHR data from almost...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Patient / Consumer, Pharma / Biotech, Provider, Survey / Study, Trends
Improving the patient experience can pay dividends you may not expect
The massive opportunity in women's longevity
Could Seniors and Rural Residents Save Hospital at Home?
Implications Of Public Policies For LGBTQI+ Population Health In The US
Calif. Farmworkers Use Telehealth to Reach Mexican Doctors

Share This Article